Follow FrankTwisk on Twitter  
   

 

 

 

 

Nunez et al:

pijn heviger en

fysiek funktioneren minder

in CGT/GET-"behandelgroep"

na 12 maanden

 

 

 

 


 

Núñez en kollega's hebben in een studie het lange termijn-effekt van CGT/GET bestudeerd.

 

In tegenstelling tot wat onze vermoeidheidsexperts van het NKCV vorig jaar beweerden

is CGT/GET werkt potentieel zeer nadelig uit bij een grote groep ME/CVS-patiënten,

hetgeen ook door dr. Maes en ondergetekende in een uitgebreide review gesteld werd.

 

Na een jaar is de kwaliteit van het leven van de CGT/GET-deelnemers niet verbeterd.

Daarentegen is de pijn sterker en het fysiek funktioneren toegenomen in de CBT/GET-groep.

 

Goh, zouden die patiënten dan toch terecht "zeuren" als het gaat om CGT/GET?

 

In de CGT/GET-groep waren de beperkingen door "emotionele" problemen vooraf groter.

Die achterstand t.o.v. de kontrolegroep herstelde zich slechts gedeeltelijk door CGT/GET.

Dus de pijn neemt toe, het fysieke funktioneren neemt af, maar je voelt je "psychisch beter".

 

Na 12 maanden waren de comorbide aandoeningen, zoals fibromyalgie, darmproblemen ("prikkelbare darm-syndroom") en schildklier-dysfunktie, in beide groepen toegenomen.

 

De auteurs stellen dat hun onderzoeksresultaten de konklusies van

de "kontroversiële" CGT/GET-review van Twisk en Maes onderschrijven....

 

Dit is de eerste onderzoeksgroep die op basis van een "randomized control trial"

(de basis voor de onterechte evidence bases"-succesclaim van de "biopyschosocialisten")

stelling durft te nemen (misschien toch niet effektief, wellicht zelfs schadelijk).

 

Als er één schaap over de dam is...

 

 


 

Citaten uit de studie:

 

 

Studies have found that HRQL [health-related quality of life] is markedly more affected in CFS than in other chronic disabling rheumatic diseases.

 

....

 

A total of 198 patients were finally diagnosed with CFS according to Fukuda criteria

and were considered for inclusion.

 

....

 

CBT contents included

  1. psycho-educational interventions to explain the multi-factorial character of CFS,
  2. progressive muscle relaxation procedures (Jacobsen) to identify muscle tension,
  3. sleep hygiene patterns to enable entry into and maintenance of phase IV sleep,
  4. detection and control of verbal and non-verbal pain-inducing attitudes,
  5. cognitive restructuring to modify non-adapted and catastrophic thought patterns,
  6. information about the relationship between vegetative and anxiety symptoms,
  7. modification of type A vehavioural patterns,
  8. improvement in assertiveness,
  9. patterns to increase attention and memory,
  10. sensorial focalization for sexual inhibition, and
  11. disease relapse prevention.

....

 

All GET sessions were personally supervised by a qualified physiotherapist,

who is a registered nurse with a diploma in physiotherapy, and

more than 20 years’ experience in general physiotherapy for neurological disease and

8 years’ experience in a third-level CFS and fibromyalgia (FM) reference unit.

 

....

 

Symptomatic pharmacological treatment was equal in the two groups and

included analgesia (paracetamol 1-3 g/day p.o.),

ibuprofen (600-1800mg/day p.o.)

if subjects reported inflammation (fever, myalgia, enlarged cervical nodes), and

zolpidem 10 mg/ night p.o.

if patients reported significant insomnia.

 

....

 

 

 

....

 

At 12 months,

there were significantly lower SF-36 physical function and bodily pain dimension scores

compared to baseline (p=0.004 and p= 0.021, respectively).

 

...

 

We also observed

a significant increase in comorbidities in both study groups at 12 months,

in agreement with other reports, suggesting a marked role of comorbidities in CFS disability.

 

....

 

The only significant differences at baseline in the SF-36 and HAQ scores

was the SF-36 emotional role score, which was lower (worse) in the intervention group

(28.07±41.69 vs. 47.62±48.77, p=0.042).

 

....

 

Although some studies cautiously conclude that

exercise therapy is a promising treatment for CFS,

the results of our study tend to support

the somewhat controversial findings of Twisk and Maes

that the combination of CBT and GET

is ineffective and not evidence-based and

may in fact be harmful in some patients,

a view supported by various surveys carried out by patient advocate groups.

 

 


 

 

 

Health-related quality of life in patients with chronic fatigue syndrome

group cognitive behavioural therapy and graded exercise versus usual treatment.

A randomised controlled trial with 1 year of follow-up.

Clin Rheumatol. 2011 Jan 15.

Núñez M, Fernández-Solà J, Nuñez E, Fernández-Huerta JM, Godás-Sieso T, Gomez-Gil E.

 

 

Abstract

 

Chronic fatigue syndrome (CFS)

produces

physical and neurocognitive disability

that significantly affects health-related quality of life (HRQL).

 

Multidisciplinary treatment

combining graded exercise therapy (GET), cognitive behavioural therapy (CBT) and

pharmacological treatment

has shown only short-term improvements.

 

To compare the effects on HRQL of

(1) multidisciplinary treatment combining CBT, GET, and pharmacological treatment, and

(2) usual treatment (exercise counselling and pharmacological treatment)

at 12 months of follow-up.

 

Prospective, randomized controlled trial

with a follow-up of 12 months after the end of treatment.

 

Patients consecutively diagnosed with CFS (Fukuda criteria)

were randomly assigned to intervention (n=60) or usual treatment (n=60) groups.

 

HRQL was assessed at baseline and 12 months

by the Medical Outcomes Study Short-Form questionnaire (SF-36).

 

Secondary outcomes

included functional capacity for activities of daily living

measured by the Stanford Health Assessment Questionnaire (HAQ) and

comorbidities.

 

At baseline, the two groups were similar,

except for lower SF-36 emotional role scores in the intervention group.

 

At 12 months,

the intervention did not improve HRQL scores,

with worse SF-36 physical function and bodily pain scores

in the intervention group.

 

Multidisciplinary treatment was not superior to usual treatment at 12 months

in terms of HRQL.

 

The possible benefits of

GET as part of multidisciplinary treatment for CFS

should be assessed on an individual patient basis.

 

 

PMID: 21234629

 

 

http://www.ncbi.nlm.nih.gov/pubmed/21234629

 

 


 

Met dank aan Rob die me attendeerde op deze studie.